NEW YORK, Aug. 8 (GenomeWeb News) - Less than four months ago, when Benitec exclusively licensed to Promega the rights to use its ddRNAi (DNA-directed RNAi) technology, the Australian company took a major step in its strategy to set up shop in the US as a therapeutics developer, executives from the companies indicated this week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.